BIAL appoints Joerg Holenz as R&D General Manager

pharmafile | November 8, 2021 | Appointment | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bial, appointments 

BIAL have announced the appointment of Jorg Holenz as R&D General Manager, replacing Patricio da Silva, who steps down after over 25 years leading the company’s R&D programmes.

António Portela, CEO of BIAL said: “Joerg Holenz has a proven track record of building and leading R&D organisations. We are confident he is the right person to help us scale up our R&D projects and to strengthen the company, allowing us to continue developing innovative medicines and, above all, to contribute to our mission of improving the quality of life of people around the world.”

BIAL is an innovative international pharmaceutical company committed to improving human health and quality of life for people across the globe.

Related Content

Sanofi axes four major players from its executive committee

Sanofi has announced it will cull its executive committee under plans orchestrated by new Chief …


Dr Richard Torbett is named as the new Chief Executive of the ABPI

The Association of the British Pharmaceutical Industry (ABPI) has appointed Dr Richard Torbett as its …


Insys Therapeutics names current CFO Andrew Long as company’s new CEO

Insys Therapeutics has said Andrew Long will take over from Saeed Motahari as the company’s …

Latest content